White Paper

In the Externalized BioPharma Industry, Seamless Collaboration Drives Life-Altering Medicines and Therapies to Patients Faster

In the Externalized BioPharma Industry, Seamless Collaboration Drives Life-Altering Medicines and Therapies to Patients Faster

Pages 13 Pages

This document presents Revvity Signals’ collaboration software portfolio designed to support modern, distributed scientific teams. It addresses the growing complexity of sponsor–CRO and cross-functional collaboration in drug discovery and development. The paper highlights challenges such as data silos, IP protection, onboarding friction, and manual communication. Revvity Signals solutions provide cloud-based environments for experiment planning, data capture, project tracking, and secure data exchange. By enabling real-time visibility, standardized workflows, and FAIR data practices, these tools improve efficiency, transparency, and decision-making while protecting intellectual property across collaborative networks.

Join for free to read